Latent profile analysis reveals the central role of psychological symptoms in driving disease severity in chronic constipation
Neurogastroenterology & Motility · 2024
DOI: 10.1111/nmo.14773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2024. Verfasst von Sophie R Abber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Florida State University, Tallahassee, Florida, USA. Hauptthemen laut MEDLINE: Constipation, Severity of Illness Index, Manometry, Anxiety. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Chronic constipation (CC) is defined by symptom criteria reflecting heterogenous physiology. However, many patients with CC have significant psychological comorbidities—an alternative definition using a biopsychosocial classification model could be warranted to inform future treatments. We sought to: (1) empirically derive psychological symptom profiles of patients with CC using latent profile analysis and (2) validate these profiles by comparing them on symptom severity, GI‐specific anxiety, body mass index (BMI), and anorectal manometry findings.
Methods
Participants included adults presenting for anorectal manometry for CC ( N = 468, 82% female, M age = 47). Depression/anxiety symptoms and eating disorder (ED) symptoms (EAT‐26) were used as indicators (i.e., variables used to derive profiles) representing unique psychological constructs. Constipation symptoms, GI‐specific anxiety, BMI, and anorectal manometry results were used as validators (i.e., variables used to examine the clinical utility of the resulting profiles). Key Results A 5‐profile solution provided the best statistical fit, comprising the following latent profiles (LPs): LP1 termed “high dieting, low bulimia;” LP2 termed “high ED symptoms;” LP3 termed “moderate ED symptoms;” LP4 termed “high anxiety and depression, low ED symptoms;” and LP5 termed “low psychological symptoms.” The low psychological symptom profile (61% of the sample) had lower abdominal and overall constipation severity and lower GI‐specific anxiety compared to the four profiles characterized by higher psychological symptoms (of any type). Profiles did not significantly differ on BMI or anorectal manometry results. Conclusions and Inferences Profiles with high psychological symptoms had increased constipation symptom severity and GI‐specific anxiety in adults with CC. Future research should test whether these profiles predict differential treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Florida State University, Tallahassee, Florida, USA.
- Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Sophie R Abber, Kyle Staller, Helen Burton-Murray
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Abber, S. R., Buchanan, K. L., Clukey, J., Joiner, T. E., Staller, K., & Burton-Murray, H. (2024). Latent profile analysis reveals the central role of psychological symptoms in driving disease severity in chronic constipation. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14773
Vancouver
Abber SR, Buchanan KL, Clukey J, Joiner TE, Staller K, Burton-Murray H. Latent profile analysis reveals the central role of psychological symptoms in driving disease severity in chronic constipation. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14773
BibTeX
@article{Abber2024,
author = {Abber, Sophie R and Buchanan, Kelly L and Clukey, Jenna and Joiner, Thomas E and Staller, Kyle and Burton-Murray, Helen},
title = {Latent profile analysis reveals the central role of psychological symptoms in driving disease severity in chronic constipation},
journal = {Neurogastroenterology & Motility},
year = {2024},
doi = {10.1111/nmo.14773}
}
EUVIMED